Morphogenesis’ Skin Cancer Vaccine Gets FDA ‘Fast Track’
Tampa company Morphogenesis, a UF startup, has received a “fast track” designation for its skin cancer vaccination from the United States Food and Drug Administration.
Tampa Company Developing Cancer Vaccines Could Receive Grant To Research Cervical Cancer Vaccine
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a Tampa-based company that has been researching and developing a vaccine for certain types of skin cancers, could be soon receiving a grant to begin research on a cervical cancer treatment for underprivileged women.
Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.
ImmuneFX Gene Therapy Could Be a Game-Changer for Cancer Treatment
UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., a clinical-stage company that develops novel cell and gene therapies based out of Tampa, recently got FDA approval to expand human clinical trials with an innovative cancer vaccine. Grit Daily interviewed Morphogenesis CEO Dr. Patricia Lawman to get more information about this technology that could […]